GW Pharmaceuticals Stock Pops After CBD Oil Gains Approval In Europe - Investor's Business Daily
GW Pharmaceuticals Stock Pops After CBD Oil Gains Approval In Europe Investor's Business DailyGW Pharmaceuticals stock popped Monday after European regulators approved the biotech company's CBD oil in two seizure disorders.